0.10 | 0.30%
| Price and Volume | |
|---|---|
| Recent Price | 33.09 |
| 52 Week High | 35.44 |
| 52 Week Low | 25.69 |
| Avg. Daily Vol. (Mil) | 9.51 |
| Beta (3 year) | 0.24 |
| Share Related Items | |
| Mkt Cap (Mil) | 55,891.80 |
| Shares Out (Mil) | 1,689.08 |
| Float (Mil) | 1,685.39 |
| Dividend Information | |
| Yield % | 4.10 |
| Annual Dividend | 1.36 |
| Payout Ratio | 45.00 |
| Financial Strength | |
| Quick Ratio | 1.20 |
| Current Ratio | 1.60 |
| LT Debt/ Equity | 0.32 |
| Total Debt / Equity | 0.33 |
| Valuation Ratios | |
| Price Earnings | 14.90 |
| Price/Sales | 2.60 |
| Price/Book | 3.42 |
| Price/Cash Flow | 9.10 |
| Per Share Data | |
| Earnings | 2.22 |
| Sales | 12.72 |
| Book Value | 9.67 |
| Cash Flow | 3.65 |
| Business Summary | |
|---|---|
| Bristol-Myers Squibb Company is a global biopharmaceutical Company, which is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceutical products on a global basis. | |
| General Information | |
| 345 Park Avenue
New York, NY 10154 |
|
| www.bms.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 27000 | |
| CEO: Lamberto Andreotti | |
| Short Interest | |
| Current Month (Mil) | 30.48 |
| Previous Month (Mil) | 31.87 |
| Short Interest Ratio (Days) | 3.20 |
| Management Effectiveness | |
| Return on Equity | 32.90 |
| Return on Assets | 16.60 |
| Return on Investments | 24.90 |
| Profitability | |
| Gross Margin | 77.80 |
| EBIT Margin | 34.40 |
| Profit Margin | 25.00 |
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,454.83 | 1,317.82 | 2,837.53 | 17.45 |
Oil *
107.26
|
|
DOWN
74.92 |
DOWN
2.86 |
DOWN
1.85 |
DOWN
0.14 |
10 Yr
1.74%
SPDR Gold
152.68
|
|
-0.60%
|
-0.22%
|
-0.07%
|
-0.80%
|
Data delayed 20 minutes |
Connect with TheStreet